Suvretta Capital Management as of Sept. 30, 2023
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 87 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Royalty Pharma Shs Class A (RPRX) | 6.0 | $111M | 4.1M | 27.14 | |
| Biohaven (BHVN) | 5.6 | $104M | 4.0M | 26.01 | |
| Arcellx Common Stock (ACLX) | 5.6 | $103M | 2.9M | 35.88 | |
| Horizon Therapeutics Pub L SHS | 4.9 | $91M | 786k | 115.69 | |
| Insmed Com Par $.01 (INSM) | 4.7 | $87M | 3.4M | 25.25 | |
| Meta Platforms Cl A (META) | 4.6 | $84M | 281k | 300.21 | |
| Amazon (AMZN) | 4.3 | $79M | 620k | 127.12 | |
| Advanced Micro Devices (AMD) | 3.9 | $72M | 697k | 102.82 | |
| Intra Cellular Therapies (ITCI) | 3.9 | $71M | 1.4M | 52.09 | |
| Microsoft Corporation (MSFT) | 3.7 | $69M | 218k | 315.75 | |
| Kura Oncology (KURA) | 3.6 | $67M | 7.3M | 9.12 | |
| Wynn Resorts (WYNN) | 2.3 | $43M | 460k | 92.41 | |
| Marinus Pharmaceuticals Com New (MRNS) | 2.3 | $42M | 5.2M | 8.05 | |
| 89bio (ETNB) | 2.2 | $42M | 2.7M | 15.44 | |
| General Electric Com New (GE) | 2.1 | $39M | 351k | 110.55 | |
| NVIDIA Corporation (NVDA) | 2.1 | $39M | 89k | 434.99 | |
| Chipotle Mexican Grill (CMG) | 2.0 | $37M | 20k | 1831.83 | |
| Global Payments (GPN) | 1.8 | $33M | 285k | 115.39 | |
| Terns Pharmaceuticals (TERN) | 1.6 | $30M | 6.0M | 5.03 | |
| Cogent Biosciences (COGT) | 1.6 | $30M | 3.1M | 9.75 | |
| Las Vegas Sands (LVS) | 1.6 | $30M | 643k | 45.84 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.5 | $28M | 3.5M | 7.99 | |
| Oracle Corporation (ORCL) | 1.5 | $27M | 255k | 105.92 | |
| Fulcrum Therapeutics (FULC) | 1.4 | $25M | 5.7M | 4.44 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $24M | 680k | 35.65 | |
| Kalvista Pharmaceuticals (KALV) | 1.3 | $23M | 2.4M | 9.63 | |
| Rh (RH) | 1.2 | $21M | 81k | 264.36 | |
| Eli Lilly & Co. (LLY) | 1.1 | $21M | 39k | 537.13 | |
| Sutro Biopharma (STRO) | 1.1 | $20M | 5.9M | 3.47 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.1 | $20M | 1.0M | 20.09 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.0 | $19M | 2.9M | 6.60 | |
| Boston Scientific Corporation (BSX) | 1.0 | $19M | 354k | 52.80 | |
| Prokidney Corp Class A Ord Shs (PROK) | 1.0 | $18M | 3.9M | 4.58 | |
| Capital One Financial (COF) | 1.0 | $18M | 182k | 97.05 | |
| Wells Fargo & Company (WFC) | 0.9 | $18M | 429k | 40.86 | |
| Apollo Global Mgmt (APO) | 0.9 | $17M | 192k | 89.76 | |
| Hilton Worldwide Holdings (HLT) | 0.9 | $17M | 114k | 150.18 | |
| Inflarx Nv (IFRX) | 0.9 | $17M | 5.7M | 2.98 | |
| McKesson Corporation (MCK) | 0.9 | $16M | 38k | 434.85 | |
| Johnson & Johnson (JNJ) | 0.8 | $14M | 90k | 155.75 | |
| UnitedHealth (UNH) | 0.7 | $14M | 27k | 504.19 | |
| Sana Biotechnology (SANA) | 0.6 | $12M | 3.0M | 3.87 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $11M | 454k | 24.75 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $11M | 597k | 17.95 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.5 | $9.5M | 7.4M | 1.29 | |
| Anaptysbio Inc Common (ANAB) | 0.5 | $8.6M | 479k | 17.96 | |
| Kezar Life Sciences (KZR) | 0.5 | $8.5M | 7.2M | 1.19 | |
| Alvotech Ordinary Shares (ALVO) | 0.5 | $8.5M | 928k | 9.12 | |
| Sanofi Sponsored Adr (SNY) | 0.3 | $6.2M | 116k | 53.64 | |
| Elanco Animal Health (ELAN) | 0.3 | $6.0M | 537k | 11.24 | |
| Arcutis Biotherapeutics (ARQT) | 0.3 | $6.0M | 1.1M | 5.31 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.3 | $5.1M | 497k | 10.20 | |
| Astrazeneca Sponsored Adr (AZN) | 0.3 | $4.8M | 71k | 67.72 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $4.5M | 41k | 108.64 | |
| Danaher Corporation (DHR) | 0.2 | $4.1M | 16k | 248.10 | |
| Thermo Fisher Scientific (TMO) | 0.2 | $3.7M | 7.3k | 506.17 | |
| Kenvue (KVUE) | 0.2 | $3.4M | 172k | 20.08 | |
| Pepgen (PEPG) | 0.1 | $2.5M | 487k | 5.08 | |
| Natera (NTRA) | 0.1 | $2.3M | 52k | 44.25 | |
| AmerisourceBergen (COR) | 0.1 | $2.2M | 13k | 179.97 | |
| Nurix Therapeutics (NRIX) | 0.1 | $2.2M | 281k | 7.86 | |
| Incyte Corporation (INCY) | 0.1 | $2.2M | 38k | 57.77 | |
| Akili Common Stock (AKLI) | 0.1 | $2.1M | 3.8M | 0.55 | |
| Abbott Laboratories (ABT) | 0.1 | $2.0M | 21k | 96.85 | |
| Aeglea Biotherapeutics Com New (SYRE) | 0.1 | $2.0M | 162k | 12.25 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $1.8M | 108k | 16.68 | |
| Gilead Sciences (GILD) | 0.1 | $1.7M | 23k | 74.94 | |
| Molecular Partners Ads (MOLN) | 0.1 | $1.7M | 400k | 4.14 | |
| Galapagos Nv Spon Adr (GLPG) | 0.1 | $1.6M | 47k | 34.55 | |
| Iqvia Holdings (IQV) | 0.1 | $1.4M | 7.2k | 196.75 | |
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $1.4M | 2.8k | 491.63 | |
| Medtronic SHS (MDT) | 0.1 | $1.4M | 18k | 78.36 | |
| Anthem (ELV) | 0.1 | $1.3M | 3.0k | 435.42 | |
| CVS Caremark Corporation (CVS) | 0.1 | $1.2M | 17k | 69.82 | |
| Illumina (ILMN) | 0.1 | $1.2M | 8.7k | 137.28 | |
| Stryker Corporation (SYK) | 0.1 | $1.2M | 4.4k | 273.27 | |
| Cigna Corp (CI) | 0.1 | $1.1M | 4.0k | 286.07 | |
| Intuitive Surgical Com New (ISRG) | 0.0 | $897k | 3.1k | 292.29 | |
| Waters Corporation (WAT) | 0.0 | $864k | 3.2k | 274.21 | |
| Avantor (AVTR) | 0.0 | $806k | 38k | 21.08 | |
| Sarepta Therapeutics (SRPT) | 0.0 | $734k | 6.1k | 121.22 | |
| Benitec Biopharma Com New (BNTC) | 0.0 | $617k | 204k | 3.02 | |
| Agilent Technologies Inc C ommon (A) | 0.0 | $558k | 5.0k | 111.82 | |
| Dex (DXCM) | 0.0 | $549k | 5.9k | 93.30 | |
| IDEXX Laboratories (IDXX) | 0.0 | $402k | 920.00 | 437.27 | |
| United Therapeutics Corporation (UTHR) | 0.0 | $307k | 1.4k | 225.87 | |
| Opy Acquisition Corp I *w Exp 09/22/202 | 0.0 | $2.0k | 73k | 0.03 |
